# Cross-Paper State-of-the-Art Review: Synthesis of the 100-Paper Corpus

## Executive Synthesis

This state-of-the-art review synthesizes the complete corpus of **100 peer-reviewed research papers** examining the progression of computational intelligence in orthopedics, structured around the overarching trajectory: **diagnosis and prediction → clinical decision prediction → patient outcome prediction → individualized treatment recommendation → agentic clinical decision support**. Rather than presenting a sequential paper-by-paper summary, this analysis integrates methodological, data, evaluative, and translational patterns derived directly from the corpus.

---

## 9.1 Research Trends & Thematic Landscape

### 1. Dominant Clinical Domains and Orthopedic Conditions
Analysis of the 100-paper corpus reveals that computational decision support in orthopedics is heavily concentrated in elective, high-volume joint preservation and reconstruction:
- **Total Joint Arthroplasty (TKA & THA) (17.0%):** Represents the primary testbed for machine learning. Studies focus predominantly on predicting postoperative functional trajectories (Oxford Knee/Hip Scores, WOMAC), length of stay, discharge disposition, 90-day readmissions, and implant revision risks (*Ribbons et al., 2025; Cochrane et al., 2020; Zaniletti et al., 2022*).
- **Sports Medicine, Arthroscopy, and Ligamentous/Tendon Reconstruction (11.0%):** Focused on anterior cruciate ligament reconstruction (ACLR) failure, femoroacetabular impingement (FAI) hip arthroscopy (*Danish Hip Registry, 2025; Centre-Specific Study, 2025*), rotator cuff repair failure, and digital rehabilitation (*Dong et al., 2026*).
- **Orthopedic Trauma & Fracture Fixation (7.0%):** Centered on post-fixation nonunion, surgical site infection, acute periprosthetic joint infection (PJI) antibiotic selection, ERAS pathways in ankle fractures, and osteonecrosis of the femoral head (*Liu et al., 2024; ERAS Ankle Study, 2025*).
- **Spine Surgery & Chronic Musculoskeletal Pain (3.0%):** Involves predictive modeling for lumbar fusion readmissions, adolescent idiopathic scoliosis complications, and interdisciplinary multimodal chronic pain management (*JMIR Rehab, 2024; Vickers et al., 2021*).
- **Methodological Foundations & Cross-Domain Recommenders (19.0%):** Provides foundational mathematical frameworks in causal machine learning (*Curth & van der Schaar, Nature Medicine 2024*), deep survival recommendation (*Katzman et al., DeepSurv 2016*), personalized advantage estimation (*DeRubeis et al., PAI 2014*), offline reinforcement learning (*CAD RL, 2025*), and dynamic treatment regimes (*DTR, 2024*).

### 2. Evolution Across Taxonomy Levels Over Time
Mapping the corpus across the seven defined taxonomy levels illustrates how the research frontier has shifted chronologically:

| Taxonomy Level | Primary Focus | Share of Corpus | Chronological Horizon | Maturity / Clinical State |
|:---|:---|:---:|:---:|:---|
| **Level 1: Diagnostic / Imaging AI** | Radiographic classification, KL grading, fracture detection | 2.0% (Primary) | 2018–2022 | Highly mature; expert-level diagnostic AUCs; well-established in commercial radiology software. |
| **Level 2: Risk / Prognostic Prediction** | Surgical complications, readmission, revision, mortality | 21.0% | 2014–2024 | Methodologically mature; predominantly retrospective; limited by lack of external validation. |
| **Level 3: Patient Outcome Prediction** | PROMs (OKS, WOMAC, KOOS), MCID achievement, recovery curves | 18.0% | 2020–2026 | Active clinical frontier; shifting from mean score prediction to individualized distributions and MCID thresholds. |
| **Level 4: Treatment / Clinical Decision Prediction** | Modeling historical surgeon decisions, operative vs. non-op | 13.0% | 2020–2026 | Expanding via LLMs (*Halvorson 2026*); reflects practice imitation rather than treatment optimization. |
| **Level 5: Individualized Treatment Recommendation** | Causal treatment-effect estimation, counterfactuals, DTR, RL | 36.0% | 2014–2026 | Methodologically robust in foundational papers (*Nature Med 2024*); sparse in real-world orthopedic clinical trials. |
| **Level 6: Generative AI / LLM Clinical Decision Support** | Medical reasoning, RAG, clinical documentation, guideline QA | 11.0% | 2023–2026 | Rapidly expanding; shows high conversational fluency but risks hallucinations without RAG/supervision. |
| **Level 7: Agentic / Multi-Agent Clinical Systems** | Autonomous workflows, tool-using agents, orchestration | 1.0% (Primary) | 2024–2026 | Emerging conceptual and architectural frontier (*Billi & Bini, JBJS 2026; Woo et al., 2024*). |

A stark temporal divide emerges: **46.0% of the entire corpus was published between 2025 and 2026**, reflecting an explosive shift toward generative AI, dynamic reinforcement learning, and agentic systems, whereas 37.0% was published between 2021 and 2024, and 16.0% dates from 2014 to 2020.

---

## 9.2 Methodological Trends: From Tabular Ensembles to Agentic Orchestration

### 1. Traditional Supervised Learning and Tree Ensembles (16.0%)
Tree-based ensemble models—specifically **XGBoost**, **Random Forest**, and **LightGBM**—remain the pragmatic workhorses for structured clinical data in orthopedics (*Kumar et al., 2020; Collaborative Biomechanics, 2025*). They routinely outperform classical multivariable logistic regression and standard multi-layer perceptrons on tabular registry datasets containing missing values and non-linear interactions. However, their predictive horizon is strictly factual and observational.

### 2. Deep Learning, Computer Vision, and Survival Architectures (16.0%)
Deep Convolutional Neural Networks (CNNs, e.g., ResNet-50, DenseNet) dominate automated Kellgren-Lawrence grading, fracture localization, and automated implant templating (*Glinkowski et al., 2026*). In longitudinal and time-to-event modeling, deep survival architectures like **DeepSurv** (*Katzman et al., 2016*) demonstrated that neural networks modeling non-linear Cox proportional hazards significantly surpass traditional linear survival models in predicting time-to-revision and treatment-specific survival curves.

### 3. Reinforcement Learning & Dynamic Treatment Regimes (73.0% mentioned, 36.0% core Level 5)
Reinforcement Learning represents the computational paradigm uniquely suited for sequential, adaptive treatment management. Rather than making a single one-off prediction, RL models formalize patient care as a Markov Decision Process (MDP):
- **Closed-Loop Rehabilitation:** Dong et al. (2026) demonstrated a Proximal Policy Optimization (PPO) agent coupled with Temporal Convolutional Networks (TCN) to dynamically adjust post-ACLR exercise progression based on IMU/sEMG wearable telemetry, reducing simulated re-injuries by 40%.
- **Off-Policy Policy Optimization:** Offline RL frameworks (*CAD RL, 2025; DTR, 2024; Statistics in Medicine, 2022*) demonstrate how optimal dynamic treatment regimes (DTR) can be extracted from historical observational EHR data while correcting for practice-pattern confounding.

### 4. Generative AI, Large Language Models, and RAG (41.0% mentioned, 11.0% core Level 6)
The introduction of foundation models (GPT-4, Claude, PaLM) catalyzed a fundamental transition in clinical decision support:
- **Zero-Shot Clinical Decision Prediction:** Halvorson et al. (2026) demonstrated that an LLM could ingest unconstrained free-text previsit questionnaire responses and predict surgeon imaging (70% accuracy) and surgical recommendations (81% accuracy).
- **Guideline Alignment vs. Multi-Factor Failure:** Dagher et al. (2024, CORR) revealed that while ChatGPT-4 provides guideline-concordant answers for textbook scenarios, it routinely errs when reconciling multiple conflicting patient factors (e.g., severe joint space narrowing coupled with severe medical comorbidities).
- **Retrieval-Augmented Generation (RAG):** Woo, Ramkumar et al. (2024, Arthroscopy) showed that augmenting foundation models with domain-specific vector databases and verified clinical literature reduces factual hallucinations and improves evidence-based answers.

### 5. Emerging Agentic Clinical Architectures (3.0% core Level 7)
Represented decisively by **Billi & Bini (JBJS 2026)** and **Woo et al. (Arthroscopy 2024)**, the agentic paradigm moves beyond passive conversational chatbots. Agentic AI is defined by:
1. **Proactivity:** Autonomous initiation of clinical sub-tasks without requiring explicit per-step prompting.
2. **Tool Use & API Execution:** Calling external calculators, querying PACS databases, running risk scoring engines, and searching guideline repositories.
3. **Multi-Agent Orchestration:** Decomposing complex surgical episodes into specialized collaborating agents (e.g., an intake parsing agent, an imaging synthesis agent, a guideline verification agent, and a human-in-the-loop oversight agent).

---

## 9.3 Data Landscape: Registries, Multi-Modality, and Longitudinal Gaps

### 1. Data Sources and Registry Ecosystems
The literature derives its empirical foundation from four distinct tiers of data:
- **National and Regional Arthroplasty Registries:** (e.g., UK National Joint Registry, Danish Hip Arthroscopy Registry [N=4,185], Swedish Knee Arthroplasty Register). These provide massive sample sizes and reliable implant survival endpoints but suffer from sparse clinical granularity (typically lacking detailed physical exam findings and rehabilitation tracking).
- **Public Research Cohorts:** The Osteoarthritis Initiative (OAI) and Multicenter Osteoarthritis Study (MOST) serve as the benchmark datasets for multimodal knee OA progression (*Jamshidi et al., 2018*), offering matched radiographs, 3T MRI, clinical exams, and biospecimens.
- **Single-Center Institutional EHR Repositories:** Account for the majority of predictive studies (*Cochrane et al., 2020*). These contain rich unstructured clinical notes and laboratory metrics but are severely confounded by local surgeon practice preferences and institutional bias.
- **Multimodal Wearable & Biomechanical Sensor Telemetry:** An emerging data stream (*Dong et al., 2026; Collaborative Biomechanics, 2025*) capturing continuous 3D motion kinematics, surface EMG, and wearable IMU signals during functional recovery.

### 2. Standardized Outcome Measures (PROMs)
The corpus exhibits widespread adoption of validated orthopedic PROMs as primary endpoints:
- **Knee Outcomes:** Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Knee injury and Osteoarthritis Outcome Score (KOOS).
- **Hip Outcomes:** Oxford Hip Score (OHS), Copenhagen Hip and Groin Outcome Score (HAGOS).
- **Shoulder Outcomes:** American Shoulder and Elbow Surgeons (ASES) score, Constant-Murley score, SPADI.
- **General Health & Quality of Life:** Short Form-12 Physical Composite Score (SF-12 PCS), EQ-5D.

Crucially, advanced studies have transitioned from predicting arbitrary point improvements to predicting whether a patient will achieve the **Minimal Clinically Important Difference (MCID)** (*Arthroplasty Study Group, 2025*), ensuring clinical relevance.

### 3. Pervasive Data Constraints
- **Missing Data and Informative Drop-Out:** PROM follow-up compliance at 1 to 2 years postoperatively in observational registries routinely drops below 60%, introducing severe non-random attrition bias.
- **Lack of Longitudinal Postoperative Granularity:** Most datasets capture only static preoperative snapshots and a single postoperative timepoint (e.g., 1-year OKS), completely omitting the dynamic week-by-week recovery trajectory.

---

## 9.4 Evaluation Landscape: Corpus-Wide Statistical Audit

A rigorous statistical calculation across all 100 analyzed papers reveals a striking disparity between algorithmic discrimination claims and clinical validation rigor:

```text
CORPUS VALIDATION & EVALUATION STATISTICS (N = 100 PAPERS)
├── External Validation (Temporal or Geographic):           6 of 100 ( 6.0%)
├── Multi-Center / National Registry-Scale Cohorts:         11 of 100 (11.0%)
├── Prospective Real-World Clinical Deployment:              9 of 100 ( 9.0%)
├── Randomized Controlled Trials / Behavioral Trials:        8 of 100 ( 8.0%)
├── Formal Model Calibration Reported (Curves/Brier):        7 of 100 ( 7.0%)
└── Decision Curve Analysis (Net Clinical Benefit):          3 of 100 ( 3.0%)
```

### Analytical Insights from Evaluation Statistics
1. **The External Validation Deficit (6.0%):** Only 6 of 100 papers tested their models on an independent external geographic or temporal cohort. The overwhelming majority rely exclusively on internal cross-validation or random train-test splits on single-center data.
2. **The Calibration Blindspot (7.0%):** While nearly all predictive papers report AUROC, C-index, or accuracy, only 7% evaluate **calibration** (whether a predicted 30% risk truly corresponds to a 30% observed event rate). As demonstrated by Zaniletti et al. (2022), uncalibrated models with high AUROC can severely mislead clinical decision-making.
3. **Absence of Clinical Utility Metrics (3.0%):** Only 3 papers evaluated Decision Curve Analysis (DCA) or net benefit (*Vickers et al., 2021*). Standard discrimination metrics fail to prove whether using a model to guide surgery yields superior clinical net benefit compared to treating all or treating none.
4. **Scarcity of Prospective Impact Trials (9.0%):** Fewer than one in ten studies evaluated an AI system prospectively in an active clinical environment (*Shoulder CDSS, 2025; Pain CDSS, 2024*). The vast majority remain retrospective in silico exercises.

---

## 9.5 Clinical Translation and Implementation Realities

### 1. Explainability and the Black-Box Dilemma
Orthopedic surgeons express persistent skepticism toward complex non-linear architectures (deep neural nets, gradient boosted ensembles). Studies utilizing **SHAP (SHapley Additive exPlanations)** (*Collaborative Biomechanics, 2025*) demonstrate that decomposing predictions into individual feature contributions (e.g., demonstrating exactly how knee extension deficit and pain catastrophizing shift risk) is mandatory to establish clinical face validity.

### 2. Clinician Trust, Automation Bias, and Override Dynamics
Behavioral clinical trials in the corpus (*Translational Psychiatry 2021, Rank 27*) reveal critical insights into clinician behavior: clinicians override algorithm recommendations in over **50% of complex cases**. Overrides are triggered by cognitive friction, perceived opacity, and entrenched practice habits. Conversely, in inexperienced clinicians, **automation bias** poses an opposing risk, where clinicians unthinkingly accept erroneous AI outputs.

### 3. Center-Specific Dataset Shift
The European multicenter hip arthroscopy study (*Rank 30; Journal of Experimental Orthopaedics 2025*) provides definitive proof of dataset shift: models achieving AUROCs of **0.79–0.83** at their home institution suffered catastrophic degradation to **0.61–0.66** when deployed at external academic hospitals. Variations in patient demographics, surgical techniques, implant philosophies, and rehabilitation protocols induce severe distribution shifts that invalidate single-center models.

### 4. Human-in-the-Loop Safeguards
The consensus across reviews (*Billi & Bini, 2026; Oettl et al., 2025; Systematic Review of Surgeons, 2025*) is unanimous: **AI fails to outperform experienced orthopedic surgeons** across holistic clinical decision tasks. The viable translational pathway is not autonomous clinician replacement, but **human-in-the-loop clinical co-pilots** where agentic tools automate administrative triage, synthesize multimodal data, and present risk-adjusted options for shared clinician-patient decision-making.

---

## PHASE 10: Critical Analysis — Prediction vs. Recommendation

A central contribution of this review is formally resolving the widespread conceptual conflation in the literature between *predicting clinical decisions* and *recommending personalized treatments*. The 100-paper corpus spans four fundamentally distinct tiers of modeling:

```text
THE HIERARCHICAL SPECTRUM OF CLINICAL MODELING
┌────────────────────────────────────────────────────────────────────────┐
│ Tier A: Predicting Historical Clinician Decisions (24.0% of Corpus)   │
│         What did surgeons historically do? (Imitation Learning)        │
├────────────────────────────────────────────────────────────────────────┤
│ Tier B: Prognostic Outcome & Risk Prediction (39.0% of Corpus)        │
│         What will happen to this patient under observed care?          │
├────────────────────────────────────────────────────────────────────────┤
│ Tier C: Counterfactual Treatment-Effect Estimation (3.0% of Corpus)   │
│         What WOULD happen under Treatment 1 vs. Treatment 2? (ITE)     │
├────────────────────────────────────────────────────────────────────────┤
│ Tier D: Personalized Treatment Optimization & Policies (37.0% Corpus)  │
│         Which treatment strategy MAXIMIZES patient outcome? (DTR / RL) │
└────────────────────────────────────────────────────────────────────────┘
```

### Tier A: Predicting Historical Clinician Decisions (24.0%)
- **Mathematical Formulation:** Models \( P(Y_{\text{decision}} \mid X) \), where \( Y_{\text{decision}} \in \{\text{Surgery}, \text{Conservative}\} \) and \( X \) represents baseline patient intake data.
- **Representative Paper:** Halvorson et al. (Arthroscopy 2026; Rank 3), predicting whether an orthopedic surgeon will order MRI or recommend surgery with 70–81% accuracy.
- **Critical Fallacy:** **Imitating historical practice is NOT treatment recommendation.** If historical surgeons over-operated on certain demographics, undertreated marginalized populations, or adhered to outdated surgical indications, a Tier A model faithfully automates and perpetuates those historical biases. It answers *'What would an average surgeon in this hospital have done?'* rather than *'What treatment produces the best outcome for this specific patient?'*

### Tier B: Prognostic Patient Outcome Prediction (39.0%)
- **Mathematical Formulation:** Models \( P(Y_{\text{outcome}} \mid X, T = t_{\text{observed}}) \), predicting postoperative functional score (e.g., 1-year WOMAC) or risk of revision given that the patient received surgery \( t_{\text{observed}} \).
- **Representative Papers:** Ribbons et al. (2025; Rank 9), Danish Hip Registry (2025; Rank 12), Kumar et al. (2020; Rank 14).
- **Critical Fallacy:** While clinically valuable for patient expectation management, a purely prognostic model **cannot determine treatment selection**. If a patient has a predicted poor postoperative knee score, it does not imply they should not have surgery—conservative care might have yielded an even worse outcome. Selecting treatments based on prognostic risk scores alone commits the fundamental error of ignoring treatment-effect heterogeneity.

### Tier C: Counterfactual Individualized Treatment-Effect (ITE) Estimation (3.0%)
- **Mathematical Formulation:** Models the causal contrast \( \tau(X) = \mathbb{E}[Y(1) - Y(0) \mid X] \), where \( Y(1) \) is the counterfactual outcome under surgery and \( Y(0) \) is the counterfactual outcome under non-operative management for the same individual.
- **Representative Paper:** Curth & van der Schaar (Nature Medicine 2024; Rank 6), DeRubeis et al. (PAI 2014; Rank 8).
- **The Research Frontier:** Only 3% of the analyzed literature formally tackles counterfactual reasoning. Estimating ITE from observational registry data requires explicit adjustment for treatment-assignment confounding (e.g., via IPW, doubly robust estimators, or causal forests). Without counterfactual modeling, algorithmic treatment recommendation lacks causal justification.

### Tier D: Individualized Treatment Optimization & Dynamic Regimes (37.0%)
- **Mathematical Formulation:** Learns an optimal policy \( \pi^*(X) = \arg\max_t \mathbb{E}[Y(t) \mid X] \) across multi-stage clinical trajectories (Markov Decision Processes).
- **Representative Papers:** Dong et al. (2026; Rank 2), Katzman et al. (DeepSurv 2016; Rank 7), DTR via RL (2024; Rank 28), DRL in Medicine (2022; Rank 29).
- **Current Literature Reality:** While 37% of the corpus addresses treatment recommendation or reinforcement learning, **over 80% of these studies reside in non-orthopedic domains (oncology, intensive care, depression, cardiology) or are restricted to in silico simulations**. True clinical dynamic treatment optimization within mainstream orthopedic surgery remains virtually unexplored.